Imatinib mesylate.
Davey
Monica P
MP
M_Davey@fccc.edu
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D001549:Benzamides; D004334:Drug Administration Schedule; D004347:Drug Interactions; D006801:Humans; D000068877:Imatinib Mesylate; D010353:Patient Education as Topic; D010879:Piperazines / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D011743:Pyrimidines / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate